Nifty

:

22147.00

Sensex

:

73088.33

151.15 (0.69%)
599.34 (0.83%)

Login

Nifty
Sensex

:
:

22147.00
73088.33

151.15 (0.69%)
599.34 (0.83%)

Ind-Swift Laboratories Ltd.

Pharmaceuticals & Drugs

Rating :

52/99

BSE: 532305 | NSE: INDSWFTLAB

Watchlist

NSE BSE

118.60

19-Apr-2024

Open
High
Low
Previous Close

115.00
121.65
114.35
116.55

Volume
Traded Value (lacs)
52 Week High
52 Week Low

797633
939.57
138.45
63.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

699.77
15.82
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,487.66
N/A
1.24

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

2.26
9.80
10.64

EBITDA CAGR (%)

10 Years
5 Years
3 Years

14.55
12.69
4.63

PAT CAGR (%)

10 Years
5 Years
3 Years

-
10.56
-

P:E (Median)

8 Years
5 Years
3 Years

3.47
7.81
11.80

P:BV (Average)

8 Years
5 Years
3 Years

0.85
0.83
0.99

EV:EBITDA (Average)

8 Years
5 Years
3 Years

8.51
6.51
5.84

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 276.28 302.41 -8.64% 270.30 287.55 -6.00% 299.01 271.52 10.12% 290.48 275.82 5.32%
Expenses 222.04 246.49 -9.92% 206.90 230.69 -10.31% 239.19 218.54 9.45% 234.14 240.74 -2.74%
EBITDA 54.24 55.91 -2.99% 63.40 56.85 11.52% 59.81 52.99 12.87% 56.34 35.08 60.60%
EBIDTM 19.63% 18.49% 23.45% 19.77% 20.00% 19.51% 19.40% 12.72%
Other Income 7.11 8.36 -14.95% 7.40 7.54 -1.86% 5.55 7.39 -24.90% 9.99 20.63 -51.58%
Interest 21.05 22.38 -5.94% 21.14 23.98 -11.84% 20.38 23.98 -15.01% 21.82 23.49 -7.11%
Depreciation 13.56 15.43 -12.12% 13.19 16.39 -19.52% 13.88 16.26 -14.64% 9.29 81.78 -88.64%
PBT 26.75 26.46 1.10% 36.47 24.02 51.83% 31.10 20.14 54.42% 8.57 -49.56 -
Tax 5.09 -2.76 - 6.38 0.00 0 14.05 0.00 0 39.48 13.63 189.66%
PAT 21.66 29.22 -25.87% 30.09 24.02 25.27% 17.05 20.14 -15.34% -30.91 -63.19 -
PATM 7.84% 9.66% 11.13% 8.35% 5.70% 7.42% -10.64% -22.91%
EPS 3.66 4.94 -25.91% 5.09 4.06 25.37% 2.88 3.41 -15.54% -5.23 -10.69 -

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 287.51 312.69 -8.05% 289.71 310.21 -6.61% 310.34 280.17 10.77% 304.25 306.65 -0.78%
Expenses 235.82 258.92 -8.92% 224.02 251.46 -10.91% 250.04 227.16 10.07% 239.53 269.95 -11.27%
EBITDA 51.69 53.76 -3.85% 65.70 58.75 11.83% 60.30 53.00 13.77% 64.71 36.69 76.37%
EBIDTM 17.98% 17.19% 22.68% 18.94% 19.43% 18.92% 21.27% 11.97%
Other Income 7.11 8.36 -14.95% 7.40 7.54 -1.86% 5.61 7.39 -24.09% 10.21 21.21 -51.86%
Interest 21.05 22.38 -5.94% 21.14 23.98 -11.84% 20.38 23.98 -15.01% 21.82 23.49 -7.11%
Depreciation 13.56 15.39 -11.89% 13.19 16.41 -19.62% 13.88 16.28 -14.74% 9.29 81.81 -88.64%
PBT 24.19 24.35 -0.66% 38.77 25.91 49.63% 31.64 20.14 57.10% 17.16 -47.40 -
Tax 4.67 -3.27 - 6.93 0.56 1,137.50% 14.24 0.22 6,372.73% 41.17 14.06 192.82%
PAT 19.53 27.62 -29.29% 31.83 25.34 25.61% 17.40 19.92 -12.65% -24.01 -61.45 -
PATM 6.79% 8.83% 10.99% 8.17% 5.61% 7.11% -7.89% -20.04%
EPS 3.29 4.65 -29.25% 5.36 4.29 24.94% 2.92 3.36 -13.10% -4.08 -10.40 -

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 1,136.07 1,151.96 988.09 856.58 751.84 724.43 728.33 674.90 638.74 645.74 940.66 Net Sales Growth -0.11% 16.58% 15.35% 13.93% 3.78% -0.54% 7.92% 5.66% -1.08% -31.35% Cost Of Goods Sold 587.56 616.84 498.15 424.99 378.85 379.33 372.09 377.00 344.31 398.54 737.30 Gross Profit 548.51 535.12 489.93 431.58 372.99 345.10 356.23 297.91 294.44 247.19 203.36 GP Margin 48.28% 46.45% 49.58% 50.38% 49.61% 47.64% 48.91% 44.14% 46.10% 38.28% 21.62% Total Expenditure 902.27 929.86 794.38 676.10 610.78 599.15 601.53 569.87 532.05 556.91 882.26 Power & Fuel Cost - 76.07 58.40 37.31 34.65 37.44 29.58 26.00 22.65 34.78 36.82 % Of Sales - 6.60% 5.91% 4.36% 4.61% 5.17% 4.06% 3.85% 3.55% 5.39% 3.91% Employee Cost - 123.03 114.92 95.47 93.58 88.94 85.22 67.53 60.74 48.20 42.59 % Of Sales - 10.68% 11.63% 11.15% 12.45% 12.28% 11.70% 10.01% 9.51% 7.46% 4.53% Manufacturing Exp. - 43.41 40.85 64.24 59.30 50.06 63.50 43.40 38.56 30.13 26.18 % Of Sales - 3.77% 4.13% 7.50% 7.89% 6.91% 8.72% 6.43% 6.04% 4.67% 2.78% General & Admin Exp. - 33.35 30.18 23.56 23.77 22.89 24.07 19.96 19.33 17.85 19.45 % Of Sales - 2.90% 3.05% 2.75% 3.16% 3.16% 3.30% 2.96% 3.03% 2.76% 2.07% Selling & Distn. Exp. - 35.74 37.95 28.74 20.24 20.41 27.00 28.12 27.89 27.31 13.09 % Of Sales - 3.10% 3.84% 3.36% 2.69% 2.82% 3.71% 4.17% 4.37% 4.23% 1.39% Miscellaneous Exp. - 1.42 13.93 1.77 0.40 0.07 0.06 7.86 18.57 0.09 13.09 % Of Sales - 0.12% 1.41% 0.21% 0.05% 0.01% 0.01% 1.16% 2.91% 0.01% 0.73% EBITDA 233.79 222.10 193.71 180.48 141.06 125.28 126.80 105.03 106.69 88.83 58.40 EBITDA Margin 20.58% 19.28% 19.60% 21.07% 18.76% 17.29% 17.41% 15.56% 16.70% 13.76% 6.21% Other Income 30.05 33.28 42.50 23.13 36.08 47.00 25.70 22.62 15.91 22.25 13.49 Interest 84.39 92.17 95.55 100.20 106.65 92.24 35.36 90.25 106.41 117.29 116.62 Depreciation 49.92 57.36 130.97 87.29 90.06 104.05 86.62 88.26 84.75 84.29 65.77 PBT 102.89 105.85 9.69 16.12 -19.56 -24.01 30.52 -50.85 -68.55 -90.49 -110.49 Tax 65.00 36.73 13.70 20.52 1.23 20.35 10.96 -16.46 -24.28 -24.12 -20.46 Tax Rate 63.17% 46.38% 171.25% 127.30% -6.29% 34.53% 38.35% 29.29% 29.21% 16.83% 14.29% PAT 37.89 42.47 -5.71 -4.40 -20.79 38.58 17.62 -39.73 -58.86 -119.16 -122.74 PAT before Minority Interest 37.89 42.47 -5.71 -4.40 -20.79 38.58 17.62 -39.73 -58.86 -119.16 -122.74 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 3.34% 3.69% -0.58% -0.51% -2.77% 5.33% 2.42% -5.89% -9.22% -18.45% -13.05% PAT Growth 271.84% - - - - 118.96% - - - - EPS 6.41 7.19 -0.97 -0.74 -3.52 6.53 2.98 -6.72 -9.96 -20.16 -20.77

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 1,191.81 1,207.31 1,038.73 891.34 779.64 756.60 762.52 697.42 653.25 660.45 965.08 Net Sales Growth -1.48% 16.23% 16.54% 14.33% 3.05% -0.78% 9.33% 6.76% -1.09% -31.57% Cost Of Goods Sold 627.08 655.59 537.43 451.44 396.66 403.36 390.56 392.19 353.01 407.39 754.92 Gross Profit 564.73 551.73 501.30 439.90 382.98 353.24 371.96 305.24 300.23 253.07 210.16 GP Margin 47.38% 45.70% 48.26% 49.35% 49.12% 46.69% 48.78% 43.77% 45.96% 38.32% 21.78% Total Expenditure 949.41 978.11 843.11 708.54 636.16 630.48 628.43 591.47 545.97 571.69 906.18 Power & Fuel Cost - 76.07 58.45 37.31 34.65 37.44 29.58 26.00 22.65 34.78 36.82 % Of Sales - 6.30% 5.63% 4.19% 4.44% 4.95% 3.88% 3.73% 3.47% 5.27% 3.82% Employee Cost - 126.17 117.40 97.86 95.92 90.98 88.12 69.65 62.76 50.65 44.95 % Of Sales - 10.45% 11.30% 10.98% 12.30% 12.02% 11.56% 9.99% 9.61% 7.67% 4.66% Manufacturing Exp. - 43.41 40.85 64.24 59.30 50.06 63.50 43.40 38.56 30.13 26.35 % Of Sales - 3.60% 3.93% 7.21% 7.61% 6.62% 8.33% 6.22% 5.90% 4.56% 2.73% General & Admin Exp. - 38.17 36.03 27.17 27.58 27.27 28.69 23.33 21.54 20.33 22.37 % Of Sales - 3.16% 3.47% 3.05% 3.54% 3.60% 3.76% 3.35% 3.30% 3.08% 2.32% Selling & Distn. Exp. - 37.29 39.03 28.74 21.65 21.30 27.92 29.06 28.87 28.33 13.95 % Of Sales - 3.09% 3.76% 3.22% 2.78% 2.82% 3.66% 4.17% 4.42% 4.29% 1.45% Miscellaneous Exp. - 1.42 13.93 1.77 0.40 0.07 0.06 7.86 18.57 0.09 13.95 % Of Sales - 0.12% 1.34% 0.20% 0.05% 0.01% 0.01% 1.13% 2.84% 0.01% 0.71% EBITDA 242.40 229.20 195.62 182.80 143.48 126.12 134.09 105.95 107.28 88.76 58.90 EBITDA Margin 20.34% 18.98% 18.83% 20.51% 18.40% 16.67% 17.59% 15.19% 16.42% 13.44% 6.10% Other Income 30.33 33.50 43.50 22.71 33.46 36.91 25.82 22.62 15.91 22.25 14.17 Interest 84.39 92.17 95.55 100.22 106.65 92.24 35.38 90.27 106.42 117.29 116.66 Depreciation 49.92 57.36 131.04 87.29 90.06 104.05 86.62 88.26 84.75 84.29 65.77 PBT 111.76 113.17 12.53 18.01 -19.77 -33.26 37.92 -49.96 -67.98 -90.56 -109.35 Tax 67.01 38.69 14.68 21.16 1.42 20.73 14.01 -16.17 -24.09 -23.98 -20.05 Tax Rate 59.96% 44.72% 117.16% 117.49% -7.18% 41.73% 38.94% 29.24% 29.10% 16.73% 14.11% PAT 44.75 47.83 -2.15 -3.15 -21.19 28.95 21.98 -39.13 -58.69 -119.37 -122.01 PAT before Minority Interest 44.75 47.83 -2.15 -3.15 -21.19 28.95 21.98 -39.13 -58.69 -119.37 -122.01 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 3.75% 3.96% -0.21% -0.35% -2.72% 3.83% 2.88% -5.61% -8.98% -18.07% -12.64% PAT Growth 291.51% - - - - 31.71% - - - - EPS 7.57 8.09 -0.36 -0.53 -3.59 4.90 3.72 -6.62 -9.93 -20.20 -20.64

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 675.35 632.56 638.69 644.61 590.29 543.37 525.88 514.69 592.35 722.86 Share Capital 59.81 59.81 59.81 59.81 48.29 46.00 45.46 41.68 41.68 40.96 Total Reserves 615.54 572.75 578.89 584.80 542.00 495.82 477.95 473.01 550.67 672.57 Non-Current Liabilities 733.03 806.37 832.95 828.33 901.32 437.80 494.76 717.24 811.33 983.36 Secured Loans 744.43 839.07 875.41 885.96 953.86 503.97 563.69 666.84 723.03 862.23 Unsecured Loans 0.00 0.00 0.00 4.93 11.72 16.52 28.32 79.48 93.11 102.17 Long Term Provisions 17.79 17.03 15.73 14.76 14.34 13.32 9.16 0.00 0.00 0.00 Current Liabilities 350.05 313.61 286.71 309.29 342.34 919.84 994.23 949.20 829.78 623.76 Trade Payables 193.13 163.32 123.96 127.12 115.70 116.58 94.95 129.45 129.74 206.34 Other Current Liabilities 96.03 81.47 89.49 99.23 134.13 491.94 493.59 316.09 249.99 23.04 Short Term Borrowings 49.02 63.86 72.58 82.94 92.52 311.31 405.70 503.66 450.05 390.97 Short Term Provisions 11.87 4.96 0.69 0.00 0.00 0.00 0.00 0.00 0.00 3.41 Total Liabilities 1,758.43 1,752.54 1,758.35 1,782.23 1,833.95 1,901.01 2,014.87 2,181.13 2,233.46 2,329.98 Net Block 585.00 626.79 737.64 842.93 900.99 924.38 1,032.35 1,098.52 1,116.60 1,172.53 Gross Block 1,330.15 1,315.21 1,298.09 1,355.90 1,378.74 1,349.06 1,406.63 1,420.29 1,404.00 1,404.04 Accumulated Depreciation 745.15 688.42 560.45 512.97 477.75 424.68 374.28 321.78 287.40 231.51 Non Current Assets 684.35 754.37 892.55 937.66 1,016.66 1,095.57 1,210.47 1,272.28 1,327.74 1,358.58 Capital Work in Progress 7.71 10.31 18.84 11.45 19.87 68.60 70.26 78.47 112.83 78.10 Non Current Investment 85.12 110.68 55.33 26.36 38.88 39.12 39.35 26.38 26.33 27.21 Long Term Loans & Adv. 4.10 3.89 65.97 56.92 56.92 63.48 54.21 68.92 71.97 80.74 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 14.31 0.00 0.00 0.00 Current Assets 1,072.67 996.15 865.80 844.56 817.29 805.44 804.41 908.85 905.72 971.39 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 427.54 414.00 354.41 342.82 316.61 316.91 343.56 356.02 348.31 377.03 Sundry Debtors 469.49 428.35 400.15 384.66 333.47 382.82 340.82 358.82 374.90 427.27 Cash & Bank 9.96 9.38 9.95 8.84 29.09 6.43 14.21 21.43 18.48 18.92 Other Current Assets 165.68 16.92 58.63 38.73 138.12 99.27 105.81 172.58 164.03 148.17 Short Term Loans & Adv. 156.66 127.51 42.66 69.51 96.30 86.22 89.49 159.33 145.42 127.09 Net Current Assets 722.63 682.54 579.09 535.27 474.95 -114.40 -189.83 -40.35 75.94 347.63 Total Assets 1,757.02 1,750.52 1,758.35 1,782.22 1,833.95 1,901.01 2,014.88 2,181.13 2,233.46 2,329.97

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 681.93 600.97 603.51 640.64 587.81 553.24 531.32 517.43 594.85 725.23 Share Capital 59.81 59.81 59.81 59.81 48.29 46.00 45.46 41.68 41.68 40.96 Total Reserves 622.12 541.17 543.70 580.83 539.53 505.69 483.39 475.74 553.17 674.95 Non-Current Liabilities 741.18 813.57 840.15 828.33 901.32 437.80 494.76 717.24 811.33 983.36 Secured Loans 752.60 847.78 884.13 885.96 953.86 503.97 563.69 666.84 723.03 862.23 Unsecured Loans 0.00 0.00 0.00 4.93 11.72 16.52 28.32 79.48 93.11 102.17 Long Term Provisions 17.79 17.03 15.73 14.76 14.34 13.32 9.16 0.00 0.00 0.00 Current Liabilities 371.09 334.47 314.52 323.07 356.00 935.93 1,005.02 950.81 832.82 630.01 Trade Payables 203.99 175.95 138.82 135.23 126.68 128.64 102.36 132.43 134.11 213.71 Other Current Liabilities 105.67 89.10 81.29 72.92 136.49 490.25 496.93 314.60 248.67 21.50 Short Term Borrowings 49.17 64.03 93.43 114.93 92.52 311.31 405.70 503.66 450.05 390.97 Short Term Provisions 12.25 5.39 0.98 0.00 0.31 5.73 0.03 0.12 0.00 3.83 Total Liabilities 1,794.20 1,748.90 1,758.09 1,792.04 1,845.13 1,926.97 2,031.10 2,185.48 2,239.00 2,338.60 Net Block 585.04 627.53 738.65 843.14 901.20 924.59 1,032.56 1,098.73 1,116.82 1,173.77 Gross Block 1,330.92 1,316.68 1,302.04 1,359.32 1,378.95 1,349.27 1,406.84 1,420.51 1,404.21 1,405.28 Accumulated Depreciation 745.88 689.15 563.38 516.18 477.75 424.68 374.28 321.78 287.40 231.51 Non Current Assets 629.68 673.56 813.91 929.00 1,009.05 1,087.71 1,202.46 1,263.78 1,319.18 1,349.72 Capital Work in Progress 7.71 10.31 18.84 11.45 19.87 68.60 70.26 78.47 112.83 78.10 Non Current Investment 30.34 29.06 35.53 17.45 31.03 31.02 31.09 17.63 17.52 17.07 Long Term Loans & Adv. 4.17 3.96 6.11 56.95 56.95 63.50 54.24 68.96 72.00 80.78 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 14.31 0.00 0.00 0.00 Current Assets 1,163.12 1,073.32 941.88 863.03 836.09 839.26 828.64 921.70 919.82 988.89 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 438.60 428.50 375.67 342.82 316.61 316.91 343.56 356.02 348.31 377.03 Sundry Debtors 505.32 454.78 432.39 396.45 350.85 407.76 357.27 372.45 389.04 443.85 Cash & Bank 18.20 21.48 11.60 10.58 29.97 9.45 16.13 22.58 19.84 20.59 Other Current Assets 201.00 16.92 56.33 38.73 138.66 105.14 111.69 170.66 162.64 147.41 Short Term Loans & Adv. 191.98 151.64 65.90 74.45 96.84 92.09 95.37 157.41 144.03 126.33 Net Current Assets 792.03 738.86 627.36 539.96 480.08 -96.67 -176.37 -29.11 87.01 358.87 Total Assets 1,792.80 1,746.88 1,755.79 1,792.03 1,845.14 1,926.97 2,031.10 2,185.48 2,239.00 2,338.61

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 182.67 136.26 135.03 123.16 -74.63 71.46 92.67 80.44 99.92 66.32 PBT 105.85 9.69 16.12 -19.56 -24.01 30.52 -50.85 -68.55 -90.49 -110.49 Adjustment 132.78 225.59 179.35 176.02 176.17 103.64 167.95 186.52 169.91 144.59 Changes in Working Capital -55.95 -99.02 -60.43 -33.30 -226.79 -62.70 -24.43 -37.53 23.91 41.47 Cash after chg. in Working capital 182.67 136.26 135.03 123.16 -74.63 71.46 92.67 80.44 103.33 75.57 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -3.41 -9.25 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -13.69 2.76 -10.17 -10.15 -2.34 -17.25 -30.99 -29.56 -36.64 -27.39 Net Fixed Assets -12.34 -8.59 50.42 31.26 19.05 59.23 21.87 18.07 -34.69 29.24 Net Investments 25.56 -55.35 -28.97 12.52 0.24 0.23 -12.97 -0.05 0.88 0.06 Others -26.91 66.70 -31.62 -53.93 -21.63 -76.71 -39.89 -47.58 -2.83 -56.69 Cash from Financing Activity -168.41 -139.59 -123.75 -133.26 99.62 -61.98 -68.90 -47.92 -63.72 -37.76 Net Cash Inflow / Outflow 0.58 -0.57 1.11 -20.25 22.66 -7.78 -7.22 2.95 -0.44 1.17 Opening Cash & Equivalents 9.38 9.95 8.84 29.09 6.43 14.21 21.43 18.48 18.92 17.75 Closing Cash & Equivalent 9.96 9.38 9.95 8.84 29.09 6.43 14.21 21.43 18.48 18.92

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 194.62 150.27 134.95 125.24 -64.40 73.09 95.57 79.43 98.40 65.53 PBT 113.17 12.53 18.01 -19.77 -33.26 37.87 -49.96 -67.98 -90.57 -109.35 Adjustment 132.78 225.66 179.35 176.02 186.26 103.64 167.95 186.30 169.93 144.59 Changes in Working Capital -51.33 -87.92 -62.41 -31.01 -214.80 -68.41 -22.42 -38.89 22.87 39.54 Cash after chg. in Working capital 194.62 150.27 134.95 125.24 -61.80 73.09 95.57 79.43 102.23 74.78 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 0.00 -2.60 0.00 0.00 0.00 -3.83 -9.25 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -13.37 4.77 -10.17 -9.10 -12.47 -17.40 -30.94 -29.56 -35.61 -27.39 Net Fixed Assets -12.34 -8.59 50.42 31.26 19.05 59.23 21.87 18.07 -34.69 29.24 Net Investments 25.56 -55.35 -28.97 12.52 0.24 0.23 -12.97 -0.05 0.88 0.06 Others -26.59 68.71 -31.62 -52.88 -31.76 -76.86 -39.84 -47.58 -1.80 -56.69 Cash from Financing Activity -185.66 -140.88 -123.75 -133.26 99.62 -61.98 -68.90 -47.92 -63.72 -37.76 Net Cash Inflow / Outflow -4.41 14.17 1.03 -17.12 22.76 -6.30 -4.27 1.94 -0.94 0.38 Opening Cash & Equivalents 21.48 11.60 10.58 29.97 9.45 16.13 22.58 19.84 20.59 18.28 Closing Cash & Equivalent 17.07 25.77 11.61 10.58 29.97 9.45 16.13 21.78 19.84 20.59

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 83.14 73.68 72.30 70.88 73.53 63.40 56.86 56.11 66.60 92.49 ROA 2.42% -0.33% -0.25% -1.15% 2.07% 0.90% -1.89% -2.67% -5.22% -5.23% ROE 9.17% -1.32% -1.04% -5.41% 12.12% 6.51% -16.41% -23.42% -36.57% -28.18% ROCE 12.67% 7.47% 8.24% 6.04% 10.65% 4.45% 2.14% 1.38% -1.52% -1.53% Fixed Asset Turnover 0.87 0.76 0.65 0.55 0.53 0.53 0.49 0.47 0.47 0.70 Receivable days 141.60 151.57 165.89 173.48 179.63 179.41 184.06 203.30 219.71 156.29 Inventory Days 132.72 140.57 147.38 159.30 158.87 163.74 184.04 195.15 198.67 157.68 Payable days 105.46 105.24 107.82 65.88 60.20 57.51 63.08 84.37 96.76 79.37 Cash Conversion Cycle 168.86 186.90 205.45 266.90 278.30 285.64 305.03 314.08 321.62 234.60 Total Debt/Equity 1.72 2.14 2.28 2.38 3.18 3.76 4.87 6.32 5.17 3.58 Interest Cover 1.86 1.08 1.16 0.82 1.64 1.81 0.38 0.22 -0.22 -0.23

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 84.25 68.33 66.35 70.21 73.01 65.58 58.08 56.78 67.21 93.07 ROA 2.70% -0.12% -0.18% -1.17% 1.53% 1.11% -1.86% -2.65% -5.22% -5.18% ROE 10.61% -0.54% -0.78% -5.56% 8.99% 7.89% -15.89% -23.11% -36.36% -27.88% ROCE 13.25% 7.88% 8.31% 5.97% 9.25% 4.59% 2.19% 1.40% -1.52% -1.46% Fixed Asset Turnover 0.92 0.80 0.67 0.57 0.56 0.56 0.51 0.48 0.48 0.71 Receivable days 144.51 154.46 168.41 174.12 182.19 181.25 185.94 206.44 223.20 158.98 Inventory Days 130.51 140.01 145.99 153.65 152.15 156.48 178.26 190.95 194.38 153.77 Payable days 105.77 106.89 110.78 68.85 63.73 60.79 64.19 12.73 29.95 80.99 Cash Conversion Cycle 169.25 187.58 203.62 258.91 270.60 276.94 300.00 384.67 387.63 231.76 Total Debt/Equity 1.71 2.33 2.56 2.48 3.21 4.38 4.77 6.25 5.12 3.56 Interest Cover 1.94 1.13 1.18 0.81 1.54 2.02 0.39 0.22 -0.22 -0.22

Top Investors:

edelweiss india special situations fund-ii

ec special situations fund

ashokkumar chandak

edelweiss india special situations fund - eisaf ii onshore fund

sri ganesh biotech private limited

conquer investment & finance pvt. ltd

investor education and protection fund (iepf)

Annual Reports:

News Update:

Ind-Swift Laboratories to incorporate wholly owned subsidiary in UAE
19th Apr 2024, 12:15 PM

The WOS intends to strategically invest in pharmaceutical and allied activities
Read More
Ind-Swift Lab. - Quarterly Results
12th Feb 2024, 16:58 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback